ATC code J04
ATC code J04 Antimycobacterials is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup J04 is part of the anatomical group J Antiinfectives for systemic use. Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ04. National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| ATC code J: Antiinfectives for systemic use |
|---|
|
| Human only |
| ATCvet only |
|
| Other ATC codes |
ATC code J04 Antimycobacterials is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J04 is part of the anatomical group J Antiinfectives for systemic use.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ04.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J04A Drugs for treatment of tuberculosis
[edit]J04AA Aminosalicylic acid and derivatives
[edit]- J04AA01 Aminosalicylic acid
- J04AA02 Sodium aminosalicylate
- J04AA03 Calcium aminosalicylate
J04AB Antibiotics
[edit]- J04AB01 Cycloserine
- J04AB02 Rifampicin
- J04AB03 Rifamycin
- J04AB04 Rifabutin
- J04AB05 Rifapentin
- J04AB06 Enviomycin
- J04AB30 Capreomycin
J04AC Hydrazides
[edit]J04AD Thiocarbamide derivatives
[edit]- J04AD01 Protionamide
- J04AD02 Tiocarlide
- J04AD03 Ethionamide
J04AK Other drugs for treatment of tuberculosis
[edit]- J04AK01 Pyrazinamide
- J04AK02 Ethambutol
- J04AK03 Terizidone
- J04AK04 Morinamide
- J04AK05 Bedaquiline
- J04AK06 Delamanid
- J04AK07 Amithiozone
- J04AK08 Pretomanid
J04AM Combinations of drugs for treatment of tuberculosis
[edit]- J04AM01 Streptomycin and isoniazid
- J04AM02 Rifampicin and isoniazid
- J04AM03 Ethambutol and isoniazid
- J04AM04 Thioacetazone and isoniazid
- J04AM05 Rifampicin, pyrazinamide and isoniazid
- J04AM06 Rifampicin, pyrazinamide, ethambutol and isoniazid
- J04AM07 Rifampicin, ethambutol and isoniazid
- J04AM08 Isoniazid, sulfamethoxazole and trimethoprim
- J04AM09 Pyrazinamide, ethambutol, isoniazid and lomefloxacin
- J04AM10 Pyrazinamide, ethambutol, protionamide and lomefloxacin
- J04AM11 Rifabutin, pyrazinamide and protionamide
- J04AM12 Rifampicin, pyrazinamide, isoniazid and levofloxacin
J04BA Drugs for treatment of lepra
[edit]- J04BA01 Clofazimine
- J04BA02 Dapsone
- J04BA03 Aldesulfone sodium
- J04BA50 Dapsone and rifampicin
- J04BA51 Dapsone, rifampicin and clofazimine
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code J04". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QJ04". WHO Collaborating Centre for Drug Statistics Methodology.